Barely Significant
← all phrases

“a decreasing trend”

47,181 sentences · 47,181 papers · 78,848 search hits before verification · confirmed specimen

Sighted at

p=0.09

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

an increasing trendP < 0.0010.0× alphagold
a decreasing trendP < 0.010.2× alphagold
Results The serum levels of 25(OH)D, 25(OH)D3, and F25(OH)D showed a decreasing trend ( z = −2.781–−3.996, P < 0.01) in RA patients with CKD progression from mild to severe, while C3-epi-25(OH)D3 showed an increasing trend ( z = 6.741, P < 0.001) and 25(OH)D2 showed no significant difference among the groups ( z = 0.976, P = 0.329).
a decreasing trendp < 0.0010.0× alphagold
Although SFC showed a decreasing trend over time at all three time points, numbers remained higher than for the PBS group ( p < 0.001, p = 0.0059 and p < 0.001, Figure 3 A) and the non-adjuvanted gE experimental vaccine group ( p = 0.0009, p = 0.0457, and p = 0.0008, Figure 3 A) at the same time point.
a decreasing trendp < 0.0010.0× alphagold
Moreover, the IOD of GFAP showed a decreasing trend over time in the control and MSC groups [control group: dpo 7 (8.59 × 10 6 ) vs. dpo 28 (3.42 × 10 6 ), p < 0.001; MSC group: dpo 7 (8.84 × 10 6 ) vs. dpo 28 (3.87 × 10 6 ), p < 0.001], while its IOD was slightly increased over time in the NSC group, but these differences were not significantly [dpo 7 (3.69 × 10 5 ), dpo 14 (9.98 × 10 5 ), dpo 28 (1.89 × 10 6 )].
a decreasing trendp < 0.0010.0× alphagold
From 2007 to 2017, the rate of inpatient care days ( Figure 3B ) showed a significant increase in the study area (city of Oulu) (AAPC = 0.9; 95% confidence interval = 0.6–1.2; p < 0.001) compared with a decreasing trend in Finland (AAPC = −4.6; 95% confidence interval = −5.0 to −4.3; p < 0.001).
a decreasing trendP < 0.0010.0× alphagold
The prevalence of advanced fibrosis in each quartile (Q 1 –Q 4 ) showed a decreasing trend as muscle strength increased ( Figure 3 ): Fibrosis FIB4 , 18.0% (SE 1.6%), 11.2% (SE, 1.4%), 8.0% (SE, 1.4%), and 2.6% (SE, 1.0%) ( P < 0.001); Fibrosis BARD , 63.9% (SE, 2.3%), 50.3% (SE, 2.4%), 42.4% (SE, 2.6%), and 29.7% (SE, 4.6%) ( P < 0.001).